viruses Article Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax® Lv-K and Fel-O-Vax® 5) Mark Westman 1,* , Jacqueline Norris 1 , Richard Malik 2 , Regina Hofmann-Lehmann 3 , Yasmin A. Parr 4 , Emma Armstrong 4 , Mike McDonald 5 , Evelyn Hall 1, Paul Sheehy 1 and Margaret J. Hosie 4 1 Sydney School of Veterinary Science, The University of Sydney, Camperdown, NSW 2006, Australia;
[email protected] (J.N.);
[email protected] (E.H.);
[email protected] (P.S.) 2 Centre for Veterinary Education, The University of Sydney, Camperdown, NSW 2006, Australia;
[email protected] 3 Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Zürich, Switzerland;
[email protected] 4 MRC—University of Glasgow Centre for Virus Research, Garscube Campus, Bearsden Road, Glasgow G61 1QH, UK;
[email protected] (Y.A.P.);
[email protected] (E.A.);
[email protected] (M.J.H.) 5 Veterinary Diagnostic Services, The University of Glasgow, Glasgow G61 1QH, UK;
[email protected] * Correspondence:
[email protected] Citation: Westman, M.; Norris, J.; Malik, R.; Hofmann-Lehmann, R.; Abstract: A field study undertaken in Australia compared the antibody responses induced in client- Parr, Y.A.; Armstrong, E.; McDonald, owned cats that had been vaccinated using two inactivated whole feline leukaemia virus (FeLV) M.; Hall, E.; Sheehy, P.; Hosie, M.J.